Added to YB: 2026-01-23
Pitch date: 2026-01-22
TEM [bullish]
Tempus AI, Inc.
-12.86%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
Market Cap
$11.6B
Pitch Price
$68.81
Price Target
N/A
Dividend
N/A
EV/EBITDA
-77.06
P/E
-54.93
EV/Sales
11.04
Sector
Life Sciences Tools and Services
Category
growth
Tempus AI (TEM) Sold Puts
TEM: Sold $50 puts exp 1/15/27 for $8.35 premium (net cost $41.65). Building world's largest oncology clinical/molecular data library creating flywheel: more sequencing → better AI insights → pharma pays for access. High-burn growth phase but dominant data moat. Regulatory risks exist.
Read full article (2 min)